The efficiency of both PARP inhibitors in abrogating poly ADP-ribose (PAR) synthesis was confirmed by western blot of PAR in LN229 and U87MG GBM cell lines (Figure S1A). This evidence concerns the gene PARP1 and glioblastoma.